Parameters | Healthy control group (I) | Untreated diabetic control group (II) | GSE-treated diabetic group (III) | MSCs-treated diabetic group (IV) | GSE/MSCs-treated diabetic group (V) |
---|---|---|---|---|---|
MDA (ng/g tissue) | 23 ± 0.1a | 80.4 ± 2.1d | 33.6 ± 3.3b | 46.2 ± 0.4c | 21.1 ± 4.1a |
GSH (pg/ g tissue) | 27.9 ± 4.1b | 18.4 ± 2.6a | 21.4 ± 11.1a | 19.1 ± 4.4a | 26.4 ± 2.8b |
IL-1β (pg/g tissue) | 44.3 ± 1.6a | 110.7 ± 0.9c | 71.9 ± 5.4b | 66.7 ± 0.4b | 42.5 ± 2.8a |
IL-12 (pg/g tissue) | 56.4 ± 1.3a | 95.5 ± 2.4c | 61.4 ± 6.1b | 59.7 ± 1.4b | 53.7 ± 3.6a |
TNF-α (pg/g tissue) | 22.4 ± 0.7a | 60.1 ± 1.6b | 23.1 ± 1.5a | 25.1 ± 3.6a | 24.5 ± 2.1a |
TLR-4 (ng/g tissue) | 18.6 ± 1.4a | 67.8 ± 4.3c | 35.4 ± 2.2b | 32.1 ± 0.9b | 22.4 ± 0.4a |